July 21st 2023, 8:00pm
Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.
July 20th 2023, 1:00pm
Therapies that target specific characteristics on kidney cancer cells are showing promise in the space, an expert explained.
July 19th 2023, 3:00pm
With new treatments being explored, it’s an exciting time for patients with kidney cancer, an expert explained.
July 19th 2023, 1:00pm
An expert explained what aspects of a patient’s disease cancer care teams use to determine the best treatment options for patients with clear cell renal cell carcinoma.
July 18th 2023, 3:00pm
Patients with BAP1-mutated renal cell carcinoma who were treated with Lynparza obtained responses with favorable side effect profiles.
July 17th 2023, 1:00pm
An expert gives an overview of up-and-coming treatments for patients with kidney cancer.
July 16th 2023, 4:00pm
Long-term follow-up data showed that Lenvima plus Keytruda continued to show benefit in patients with metastatic kidney cancer.
July 15th 2023, 7:00pm
Immunotherapy combinations tended to improve outcomes for patients with metastatic kidney cancer who go on to receive surgery.
July 15th 2023, 2:00pm
Radiation is an emerging treatment modality in kidney cancer. Research shows that it is effective and helps patients maintain a good quality of life.
July 14th 2023, 9:00pm
Keytruda after nephrectomy improved disease-free survival rates in patients with clear cell renal cell carcinoma regardless of disease risk or stage.
FDA Approves Initiation of a New Trial in Recurrent Glioblastoma
The Benefit of Clinical Trial Enrollment for Patients With Cancer
Addressing Gaps, Challenges and Disparities in AYA Cancer Care
Unexpected Challenges 11 Years After Breast Cancer